Found: 22
Select item for more details and to access through your institution.
Antibody drug conjugates: Design implications for clinicians.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 907, doi. 10.1177/10781552241228827
- By:
- Publication type:
- Article
Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 941, doi. 10.1177/10781552241237752
- By:
- Publication type:
- Article
Successful desensitization in a patient with recurrent anaplastic oligodendroglioma presenting with procarbazine-mediated anaphylaxis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 937, doi. 10.1177/10781552241226861
- By:
- Publication type:
- Article
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 902, doi. 10.1177/10781552231196130
- By:
- Publication type:
- Article
Characterization of education, technical practices and attitudes of Portuguese pharmacy technicians towards manipulation of cytotoxic drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 893, doi. 10.1177/10781552231190025
- By:
- Publication type:
- Article
Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 930, doi. 10.1177/10781552241247007
- By:
- Publication type:
- Article
Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 919, doi. 10.1177/10781552241241317
- By:
- Publication type:
- Article
Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah's Witness sarcoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 950, doi. 10.1177/10781552241240734
- By:
- Publication type:
- Article
Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 945, doi. 10.1177/10781552241240444
- By:
- Publication type:
- Article
Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 884, doi. 10.1177/10781552231190016
- By:
- Publication type:
- Article
Assessing floor contamination by antineoplastic agents in a Japanese medical institution specializing in cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 880, doi. 10.1177/10781552231190015
- By:
- Publication type:
- Article
Factors associated with potentially inappropriate medications in elderly with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 873, doi. 10.1177/10781552231190009
- By:
- Publication type:
- Article
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 867, doi. 10.1177/10781552231190005
- By:
- Publication type:
- Article
Fludarabine-induced bradycardia in allogeneic hematopoietic stem cell transplantation: A retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 860, doi. 10.1177/10781552231189868
- By:
- Publication type:
- Article
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 853, doi. 10.1177/10781552231189867
- By:
- Publication type:
- Article
Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 844, doi. 10.1177/10781552231189706
- By:
- Publication type:
- Article
Determination of drug–drug interaction in breast cancer patients receiving doxorubicin and cyclophosphamide regimen.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 830, doi. 10.1177/10781552231189700
- By:
- Publication type:
- Article
Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 823, doi. 10.1177/10781552231189695
- By:
- Publication type:
- Article
Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 811, doi. 10.1177/10781552231189461
- By:
- Publication type:
- Article
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 802, doi. 10.1177/10781552231189199
- By:
- Publication type:
- Article
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 792, doi. 10.1177/10781552231187305
- By:
- Publication type:
- Article
Enhancement of paediatric oncology pharmacy practices in a low–middle-income country through teaching and training using the My Child Matters Grant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 786, doi. 10.1177/10781552231184779
- By:
- Publication type:
- Article